Compounds > quinacrine

quinacrine and bmn 673

quinacrine has been researched along with bmn 673 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Kundu, CN; Sethy, C1
Bhal, S; Das, B; Das, C; Dash, SR; Kundu, CN; Paul, S; Sethy, C; Sinha, S1

Other Studies

2 other study(ies) available for quinacrine and bmn 673

ArticleYear
PARP inhibitor BMN-673 induced apoptosis by trapping PARP-1 and inhibiting base excision repair via modulation of pol-β in chromatin of breast cancer cells.
    Toxicology and applied pharmacology, 2022, 02-01, Volume: 436

    Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Chromatin; DNA Damage; DNA Repair; Female; Flap Endonucleases; Humans; MCF-7 Cells; Phthalazines; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Quinacrine

2022
Talazoparib enhances the quinacrine-mediated apoptosis in patient-derived oral mucosa CSCs by inhibiting BER pathway through the modulation of GCN5 and P300.
    Medical oncology (Northwood, London, England), 2023, Nov-08, Volume: 40, Issue:12

    Topics: Animals; Antineoplastic Agents; Apoptosis; Chromatin; DNA; DNA Damage; DNA Repair; Humans; Mice; Mouth Mucosa; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Quinacrine

2023